Capital for Cures – Healthcare Investment Networking Event

We are excited to invite you to Capital for Cures, an exclusive networking event co-organized by Slate Mountains Capital and SS&C Intralinks, on November 14th, 2024 in Frankfurt.

Following the successful Private Equity event recently hosted by SS&C Intralinks, which attracted over 80 top industry participants, we are now partnering to bring you the next edition under the Capital for Cures banner, focusing on the healthcare sector.

With the US election results and new European Commission mandates poised to reshape the investment landscape, this event will gather investors, buy-side and sell-side professionals, and pharmaceutical leaders to explore critical questions, including:

• Will we see an increase in IPOs and M&A activity?
• How are venture capital firms adapting to market shifts?
• What role will alternative deal structures play in 2025?

The event will feature Dr. Bodo Alexander Marr (Vice President, Head of M&A/Treasury at MorphoSys AG), Roby Kanichavy (Head of Technologies and Externalizations at Merck KGaA), and Tobias Goetz (Director, Corporate Development / M&A at Fresenius).

Host or Publisher Slate Mountains Capital